| Basics |
| Company: |
Elanco Animal Health Incorporated |
| IPO Date: |
September 17, 2018 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$5.69B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.35 | 1.60%
|
| Avg Daily Range (30 D): |
$0.15 | 1.24%
|
| Avg Daily Range (90 D): |
$0.18 | 1.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.31M |
| Avg Daily Volume (30 D): |
3.66M |
| Avg Daily Volume (90 D): |
3.79M |
| Trade Size |
| Avg Trade Size (Sh.): |
153 |
| Avg Trade Size (Sh.) (30 D): |
139 |
| Avg Trade Size (Sh.) (90 D): |
138 |
| Institutional Trades |
| Total Inst.Trades: |
13,670 |
| Avg Inst. Trade: |
$3.44M |
| Avg Inst. Trade (30 D): |
$2.68M |
| Avg Inst. Trade (90 D): |
$2.68M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$12.3M |
| Avg Closing Trade (30 D): |
$7.45M |
| Avg Closing Trade (90 D): |
$7.32M |
| Avg Closing Volume: |
573.88K |
|
|
|
|
| News |
Jan 8, 2025 @ 3:55 PM
Growth Trends in the Porcine Vaccines Market, Fore...
Source: Researchandmarkets.Com
|
Dec 6, 2024 @ 9:00 PM
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Dec 5, 2024 @ 2:03 AM
ELAN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourage...
Source: N/A
|
Dec 1, 2024 @ 9:00 PM
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Dec 1, 2024 @ 4:33 PM
ELAN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, En...
Source: N/A
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$.41
|
$.74
|
$-.1
|
|
Diluted EPS
|
$.4
|
$.73
|
$-.1
|
|
Revenue
|
$ 4.45B
|
$ 1.03B
|
$ 1.18B
|
|
Gross Profit
|
$ 2.44B
|
$ 538M
|
$ 689M
|
|
Net Income / Loss
|
$ 205M
|
$ 364M
|
$ -50M
|
|
Operating Income / Loss
|
$ 412M
|
$ 559M
|
$ -32M
|
|
Cost of Revenue
|
$ 2.02B
|
$ 492M
|
$ 495M
|
|
Net Cash Flow
|
$ 121M
|
$ 74M
|
$ 71M
|
|
PE Ratio
|
29.51
|
|
|
|
